411 results
Ianalumab Effective for Immune Thrombocytopenia in Phase III
Proteins, Antibodies & ADCs

Ianalumab Effective for Immune Thrombocytopenia in Phase III

News
Dec , 2025
Breyanzi Gets Green Light from FDA for Marginal Zone Lymphoma

Breyanzi Gets Green Light from FDA for Marginal Zone Lymphoma

News
Dec , 2025

Delivering Next-Generation Regenerative Medicine: Bioengineering, Clinical Translation & the Future of Therapeutics

Announcement
Dec , 2025
Understanding the CGT Investment Landscape: Interview with Sven Kili, Partner, Saisei Ventures
Cell & Gene

Understanding the CGT Investment Landscape: Interview with Sven Kili, Partner, Saisei Ventures

News
Dec , 2025
Avenzo Granted Fast Track Designation by FDA for Bispecific ADC

Avenzo Granted Fast Track Designation by FDA for Bispecific ADC

News
Dec , 2025
Tissue Engineering and Stem Cell Development: Insights from a Cell 2025 Roundtable
Cell & Gene

Tissue Engineering and Stem Cell Development: Insights from a Cell 2025 Roundtable

News
Dec , 2025
Navigating Regulatory Considerations for Cell and Gene Therapies: Insights from a Cell 2025 Roundtable
Cell & Gene

Navigating Regulatory Considerations for Cell and Gene Therapies: Insights from a Cell 2025 Roundtable

News
Dec , 2025
A Novel Engineered CHO Host Cell Line For High-Titer Production Of Biopharmaceuticals
Cell & Gene

A Novel Engineered CHO Host Cell Line For High-Titer Production Of Biopharmaceuticals

Technology Spotlight
Nov , 2025
One Reactor To Rule Them All: A Novel Bionic Bioreactor for Sensitive Stem & Immune-Cells
Cell & Gene

One Reactor To Rule Them All: A Novel Bionic Bioreactor for Sensitive Stem & Immune-Cells

Technology Spotlight
Nov , 2025
Assessment Of Tumour Cell Susceptibility To Killing By Antigen-Specific And Nonspecific CD8+T Cells
Cell & Gene

Assessment Of Tumour Cell Susceptibility To Killing By Antigen-Specific And Nonspecific CD8+T Cells

Technology Spotlight
Nov , 2025
An All Stakeholder Approach To Cell & Gene Therapy
Cell & Gene

An All Stakeholder Approach To Cell & Gene Therapy

Market Insight
Nov , 2025
Scaling Up Complex Organoid Models: Challenges And Solutions
Cell & Gene

Scaling Up Complex Organoid Models: Challenges And Solutions

Market Insight
Nov , 2025
Exploring the MHRA's Advancements for ATMP Development and Regulation
Cell & Gene

Exploring the MHRA's Advancements for ATMP Development and Regulation

Market Insight
Nov , 2025
Ailux Partner with Lilly in $345m Deal to Advance Bispecific Antibody Development
Proteins, Antibodies & ADCs

Ailux Partner with Lilly in $345m Deal to Advance Bispecific Antibody Development

News
Nov , 2025
Caribou Announces Positive Data for Off-the-Shelf CAR T
Cell & Gene

Caribou Announces Positive Data for Off-the-Shelf CAR T

News
Nov , 2025
Designing Next Generation Biomaterials: Peptide Hydrogels for Culture, Printing & Regeneration
Cell & Gene

Designing Next Generation Biomaterials: Peptide Hydrogels for Culture, Printing & Regeneration

News
Nov , 2025
Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms
Cell & Gene

Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Thought Leadership
Nov , 2025
MIT Develop New Method of AAV Manufacture for Gene Therapy
Cell & Gene

MIT Develop New Method of AAV Manufacture for Gene Therapy

News
Nov , 2025
GSK Acquires Rights to ADC for Prostate Cancer for £268m
Proteins, Antibodies & ADCs

GSK Acquires Rights to ADC for Prostate Cancer for £268m

News
Nov , 2025
Animal Free 3D Cell Culture and Organoid Growth: Interview with Aline Miller, University of Manchester
Cell & Gene

Animal Free 3D Cell Culture and Organoid Growth: Interview with Aline Miller, University of Manchester

Thought Leadership
Nov , 2025
Developing CAR T for Solid Tumours: Interview with John Bridgeman, ImmunoKey
Cell & Gene

Developing CAR T for Solid Tumours: Interview with John Bridgeman, ImmunoKey

Thought Leadership
Nov , 2025

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.